Kiromic Biopharma, Inc. (61) | Business Finance (14)
Browse by Subcategory
Recent Contracts
-
Form of Underwriting Agreement
(Filed With SEC on June 25, 2021)
-
Form of Representatives Warrant
(Filed With SEC on June 25, 2021)
-
Membership Interest Purchase Agreement dated as of June 14, 2021 among Kiromic BioPharma, Inc., In Silico Solution, LLC and Michael Ryan
(Filed With SEC on June 17, 2021)
-
Series B Preferred Stock Purchase Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors
(Filed With SEC on May 11, 2020)
-
Investors Rights Agreement, dated September 7, 2019, among Kiromic BioPharma, Inc. and certain investors
(Filed With SEC on May 11, 2020)
-
Convertible Promissory Note issued by Kiromic BioPharma, Inc. to Prevail Partners on May 30, 2019
(Filed With SEC on May 11, 2020)
-
Form of Representatives Warrant Agreement
(Filed With SEC on November 30, 2020)
-
Underwriting Agreement, dated October 15, 2020
(Filed With SEC on October 21, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on July 13, 2020)
-
Form of Representatives Warrant
(Filed With SEC on July 13, 2020)
-
Form of Warrant to Purchase Common Stock
(Filed With SEC on May 11, 2020)
-
Form of Securities Purchase Agreement for Series A-1 Preferred Stock
(Filed With SEC on May 11, 2020)
-
Form of 17% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors
(Filed With SEC on May 11, 2020)
-
Form of 7% Convertible Promissory Note issued by Kiromic BioPharma, Inc. to certain investors
(Filed With SEC on May 11, 2020)
